Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Regeneron Pharmaceuticals
(NQ:
REGN
)
958.64
+1.64 (+0.17%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Regeneron Pharmaceuticals
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
31
32
Next >
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 10 Years
June 07, 2023
Via
Benzinga
3 Biotech Stocks to Sell in June Before They Crash and Burn
June 06, 2023
Investors should get out of these biotech stocks to sell now that the Covid-19 pandemic is largely over. These's worse in store for them.
Via
InvestorPlace
Regeneron Pharmaceuticals Unusual Options Activity For June 05
June 05, 2023
Via
Benzinga
Wall Street Says These 2 Stocks May Double. Should You Buy Them?
June 05, 2023
Both of these stocks have declined over the past year.
Via
The Motley Fool
Regeneron Pharmaceuticals Unusual Options Activity
May 30, 2023
Via
Benzinga
Regeneron Reveals Updated Data From Multiple Myeloma Study, Showing Response Rate Of 71%
May 26, 2023
Via
Benzinga
Regeneron Pharmaceuticals Unusual Options Activity For May 25
May 25, 2023
Via
Benzinga
Here's How Much $100 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth Today
May 22, 2023
Via
Benzinga
This Is What Whales Are Betting On Regeneron Pharmaceuticals
May 19, 2023
Via
Benzinga
How Is The Market Feeling About Regeneron Pharmaceuticals?
May 15, 2023
Via
Benzinga
Looking At Regeneron Pharmaceuticals's Recent Unusual Options Activity
May 08, 2023
Via
Benzinga
A Good Week For The Market But A Pause In The Biotech Rally
May 22, 2023
Healthcare stocks have been lagging in 2023 with the XLV down 1.97% MTD and 3.34% YTD with CVS and UNH contributing to the weakness.
Via
Talk Markets
Sanofi-Regeneron Highlight Dupixent Data, Say Drug Benefit Was Swift, Sustained
May 22, 2023
Via
Benzinga
The 7 Growth Stocks You Need to Own Now for Maximum Returns
May 17, 2023
If you still want to stick around in the market for max returns, these growth stocks to buy should be intriguing for speculators.
Via
InvestorPlace
AI-Run ETF Dumps Apple In Favor Of This Chip Stock And Hints At New Opportunity Brewing In Market
May 12, 2023
Via
Benzinga
If You Invested $100 In This Stock 10 Years Ago, You Would Have $300 Today
May 05, 2023
Via
Benzinga
Why Regeneron Pharmaceuticals Stock Is Tanking Today
May 04, 2023
Investors are worried about Eylea's falling sales.
Via
The Motley Fool
Regeneron Pharma Dives As Competition Undercuts Its Biggest Moneymaker
May 04, 2023
Eylea sales fell and missed expectations in the U.S.
Via
Investor's Business Daily
Regeneron Pharmaceuticals Unusual Options Activity
May 03, 2023
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
May 10, 2023
Via
Benzinga
2 Cathie Wood Stocks That Can Get You Through Any Recession
May 10, 2023
Shares of both companies moved higher even as the stock market fell last year.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
May 09, 2023
Via
Benzinga
Why Regeneron Pharmaceuticals Shares Are Trading Lower Today
May 04, 2023
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) earned adjusted EPS of $10.09, down 12% Y/Y, beating
Via
Benzinga
Small & Mid Cap Life Science Stock Portfolio: Some Good Picks In A Stalled Sector
May 01, 2023
A pivotal week looks to be shaping up with the usual macro concerns arising, such as a Fed meeting and big earnings waiting just around the corner. One possible path to help navigate around these macro...
Via
Talk Markets
Where Regeneron Pharmaceuticals Stands With Analysts
May 01, 2023
Via
Benzinga
Market Rally Finishes Strong; Regional Banks, Fed Rate Hike, Jobs Report, Apple In Focus: Weekly Review
May 05, 2023
The major indexes retreated for most of the week on banking fears,
Via
Investor's Business Daily
Could Government Drug-Price Negotiations Sound The Death Knell For Biotech Stocks?
April 28, 2023
Experts fear a change in how Medicare buys drugs could slam biotech and pharma companies.
Via
Investor's Business Daily
Alnylam - Regeneron Partnered Alzheimer's Candidate's Initial Data Sounds Promising, Analyst Says
April 27, 2023
Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) and its partner Regeneron Pharmaceuticals Inc (NASDAQ: REGN)
Via
Benzinga
Sanofi Posts Upbeat Q1 Earnings, Sales Buoyed By Blockbuster Dupixent Sales
April 27, 2023
French drugmaker Sanofi SA (NASDAQ: SNY) reported an 8.7% Y/Y (+9.3% on constant currency) rise in
Via
Benzinga
EXCLUSIVE: SAB Biotherapeutics Releases Topline Data From Discontinued COVID Antibody Trial
April 26, 2023
SAB Biotherapeutics Inc (NASDAQ: SABS) has revealed topline results from the Phase 3 National Institutes of Health's (NIH) ACTIV-2 trial that assessed SAB-185 in non-hospitalized COVID-19 patients at...
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
31
32
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.